Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Apps as medical devices - UK regulator updates its guidance

MHRA moves to help firms' health apps comply with its rules

Mersey Burns iPhone health appThe UK's regulator the MHRA has updated its guidance on whether a health app should be subject to medical device oversight.

A number of apps and pieces of stand-alone software that are already on the market have so far been classified as medical devices and consequently fall within the MHRA's remit.

They include those that gather data from a person or a diagnostic device, such as diet, heartbeat, or blood glucose levels and then analyse and interpret the data to make a diagnosis, prescribe a medicine or recommend treatment.

John Wilkinson, MHRA's director of medical devices, said: “We live in an increasingly digital world, both healthcare professionals, patients and the public are using software and stand-alone apps to aid diagnosis and monitor health.

“Where apps or stand-alone software make a diagnosis or recommend a treatment, people should check for CE-marking before using their apps and developers should make sure they are complying with the appropriate medical device regulations.”

In the UK, as in the rest of Europe, software and apps that are defined as medical devices must gain a CE mark (kitemark) in line with the EU medical device directives to show they are 'regulated and acceptably safe to use and also perform in the way the manufacturer/ developer intends them to'.

The first health app to be classified as a medical device was the Mersey Burns app (pictured above), which was developed by doctors at the Mersey Regional Burns and Plastic Surgery Unit. Other apps that also have a CE mark include OncoAssist and Airstrip's patient monitoring apps.

The MHRA's new guidance on health apps as medical devices is available in an interactive pdf that developers through its processes.

Releasing the guidance the MHRA stressed that apps that give incorrect diagnoses or prescribe inappropriate treatments could have severe and potentially life-threatening consequences.

Wilkinson added: “Patient safety is our priority. We continue to encourage people to report any safety or performance issues involving medical devices, including apps, to MHRA via our Yellow Card Scheme online.”

26th August 2016

From: Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health Communications

Formerly known as Packer Forbes Communications, Four Health Communications is an award-winning, integrated healthcare communications agency for pharma, biotech, NGOs...

Latest intelligence

Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...

Infographics